Effects of Genital Ulcer Disease and Herpes Simplex Virus Type 2 on the Efficacy of Male Circumcision for HIV Prevention: Analyses from the Rakai Trials
Tóm tắt
Từ khóa
Tài liệu tham khảo
B Auvert, 2005, Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial., PLoS Med, 2, e298, 10.1371/journal.pmed.0020298
RC Bailey, 2007, Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial., Lancet, 369, 643, 10.1016/S0140-6736(07)60312-2
RH Gray, 2007, Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial., Lancet, 369, 657, 10.1016/S0140-6736(07)60313-4
HA Weiss, 2000, Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis., Aids, 14, 2361, 10.1097/00002030-200010200-00018
R Szabo, 2000, How does male circumcision protect against HIV infection?, BMJ, 320, 1592, 10.1136/bmj.320.7249.1592
BK Patterson, 2002, Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture., Am J Pathol, 161, 867, 10.1016/S0002-9440(10)64247-2
SG McCoombe, 2006, Potential HIV-1 target cells in the human penis., Aids, 20, 1491, 10.1097/01.aids.0000237364.11123.98
BA Donoval, 2006, HIV-1 target cells in foreskins of African men with varying histories of sexually transmitted infections., Am J Clin Pathol, 125, 386, 10.1309/JVHQVDJDYKM58EPH
AA Tobian, 2009, Male circumcision for the prevention of HSV-2 and HPV infections and syphilis., N Engl J Med, 360, 1298, 10.1056/NEJMoa0802556
HA Weiss, 2006, Male circumcision and risk of syphilis, chancroid, and genital herpes: a systematic review and meta-analysis., Sex Transm Infect, 82, 101, 10.1136/sti.2005.017442
J Sobngwi-Tambekou, 2009, Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa., J Infect Dis, 199, 958, 10.1086/597208
JA Rottingen, 2001, A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known?, Sex Transm Dis, 28, 579, 10.1097/00007435-200110000-00005
A Wald, 2002, Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis., J Infect Dis, 185, 45, 10.1086/338231
L Corey, 2007, Synergistic copathogens–HIV-1 and HSV-2., N Engl J Med, 356, 854, 10.1056/NEJMe068302
JL Gamiel, 2008, Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda., Clin Vaccine Immunol, 15, 888, 10.1128/CVI.00453-07
AJ Barros, 2003, Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio., BMC Med Res Methodol, 3, 21, 10.1186/1471-2288-3-21
A Risbud, 1999, The etiology of genital ulcer disease by multiplex polymerase chain reaction and relationship to HIV infection among patients attending sexually transmitted disease clinics in Pune, India., Sex Transm Dis, 26, 55, 10.1097/00007435-199901000-00009
KA Orle, 1996, Simultaneous PCR detection of Haemophilus ducreyi, Treponema pallidum, and herpes simplex virus types 1 and 2 from genital ulcers., J Clin Microbiol, 34, 49, 10.1128/JCM.34.1.49-54.1996
LS Freedman, 1992, Statistical validation of intermediate endpoints for chronic diseases., Stat Med, 11, 167, 10.1002/sim.4780110204
NP Jewell, 2004, Statistics for epidemiology
J Sobngwi-Tambekou, 2009, Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa., J Infect Dis, 199, 958, 10.1086/597208
J Zhu, 2009, Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition., Nat Med, 15, 886, 10.1038/nm.2006
C Celum, 2008, Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial., Lancet, 371, 2109, 10.1016/S0140-6736(08)60920-4